Bionano Genomics Inc (BNGO)
0.2559
-0.02
(-7.58%)
USD |
NASDAQ |
Nov 14, 16:00
0.256
0.00 (0.00%)
After-Hours: 07:23
Bionano Genomics Free Cash Flow (Quarterly): -21.06M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -21.06M |
| March 31, 2024 | -28.16M |
| December 31, 2023 | -30.52M |
| September 30, 2023 | -26.37M |
| June 30, 2023 | -37.21M |
| March 31, 2023 | -32.77M |
| December 31, 2022 | -36.08M |
| September 30, 2022 | -29.76M |
| June 30, 2022 | -28.80M |
| March 31, 2022 | -33.48M |
| December 31, 2021 | -26.74M |
| September 30, 2021 | -20.25M |
| June 30, 2021 | -12.47M |
| March 31, 2021 | -13.93M |
| December 31, 2020 | -12.10M |
| Date | Value |
|---|---|
| September 30, 2020 | -10.96M |
| June 30, 2020 | -7.218M |
| March 31, 2020 | -8.032M |
| December 31, 2019 | -9.405M |
| September 30, 2019 | -7.288M |
| June 30, 2019 | -6.346M |
| March 31, 2019 | -6.552M |
| December 31, 2018 | -4.102M |
| September 30, 2018 | -6.230M |
| June 30, 2018 | -3.144M |
| March 31, 2018 | -6.799M |
| December 31, 2017 | -3.091M |
| September 30, 2017 | -5.929M |
| June 30, 2017 | -5.378M |
| March 31, 2017 | -7.437M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-37.21M
Minimum
Jun 2023
-7.218M
Maximum
Jun 2020
-22.38M
Average
-26.37M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Revvity Inc | 125.57M |
| Bruker Corp | 5.80M |
| Azenta Inc | -4.802M |
| Harvard Bioscience Inc | -1.953M |
| Akoya Biosciences Inc | -11.21M |